Back

Locus-specific stratification and prioritization unveil high risk genes underlying hyperuricemia

Zhang, J.; Guo, Y.; Gong, L.; Xia, L.; Liu, Q.; Wang, K.; Wang, Q.; Liu, Z.; Qin, Z.; Shi, S.; Yang, J.

2024-03-08 genetic and genomic medicine
10.1101/2024.03.06.24303846 medRxiv
Show abstract

The development of alternative medications for urate-lowering therapies is imperative for patients that are intolerant to current treatments. Despite GWAS have identified hundreds of loci associated with serum urate levels, the mechanistic understanding and discovery of drug targets remain difficult. This difficulty arises from the multiple-independent-associations challenge in the genomic studies of complex diseases as hyperuricemia. Here, we introduced a locus-specific stratification (LSS) and gene regulatory prioritization score (GRPS) approach to address the multiple-independent-associations challenge. By integrating with kidney single-cell chromatin accessibility and gene expression, LSS identified functional SNPs, regulatory elements, and genes for 118 loci. The interpretability was increased by 1.4 to 5.2 fold. GRPS prioritized genes and nominated under-explored drug target with high confidence, which was validated using CRISPR activation and phenotypic assays. Our findings not only identified top causal genes but also proposed the regulatory mechanisms for pathogenic genes, expanding our knowledge of the genetic contribution in complex diseases as hyperuricemia. One-sentence summaryA novel approach to comprehensively explore genetic contribution and nominate reliable causal genes for complex diseases as hyperuricemia.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.